$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Is adjuvant treatment required during the recovery period of bone marrow transplantation with ivonib (Tosuvo)?
2026-02-01 22:25:32
Check Details
What is the approximate price per bottle of Mitotane that patients can afford?
2026-02-01 22:25:32
Check Details
Market price analysis of pemigatinib as a targeted drug in treatment
2026-02-01 22:25:32
Check Details
Whether Erdafitinib is currently included in the national medical insurance and its actual reimbursement rate
2026-02-01 22:25:32
Check Details
Erlotinib (Loret) can be taken continuously for up to several years in clinical practice and its long-term safety analysis
2026-02-01 22:25:32
Check Details
Whether tofacitinib and tofacitinib citrate tablets are equivalent and the differences between different versions
2026-02-01 22:25:32
Check Details
Analysis of the key performance of cycloserine’s actual role and efficacy in clinical anti-infective treatment
2026-02-01 22:25:32
Check Details
Comprehensive explanation of common adverse reactions and monitoring key points of linezolid (Siwo) in clinical use
2026-02-01 22:25:32
Check Details
Is ribociclib (Kaillon) a chemotherapy drug or a targeted drug and its specific positioning in clinical treatment?
2026-02-01 22:25:32
Check Details
A comprehensive analysis of the indications, usage, dosage and safety information in the official instructions of Cemiplimab
2026-02-01 22:25:32
Check Details
Analysis of the core functions and clinical application value of Daprodustat in the treatment of anemia
2026-02-01 22:25:32
Check Details
The scope of approved indications for durvalumab (durvalumab) and its clinical application in different cancer types
2026-02-01 22:25:32
Check Details
1
2
...
2429
2430
2431
2432
2433
2434
2435
...
10240
10241
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Weight Gain and Edema Management, Monitoring of Repotrectinib (Augtyro) During Treatment
2
Ixazomib (Ninlaro) Dosing Schedule, Missed Dose Management and Cycle Planning in 28‑Day Regimen
3
Ponatinib in the PACE Phase II Trial: Response Data in Resistant CML and Ph+ ALL
4
Selumetinib for NF1-Related Plexiform Neurofibromas: Time to Response and Response Assessment
5
How to Take Tucatinib (Tukysa): Dosing Schedule, Combination Use & Missed Dose Guidance
6
Ganaxolone Common Side Effects: Somnolence, Sedation and Safety Notes
7
Baxdrostat: Efficacy and Safety of a Novel Aldosterone Synthase Inhibitor
8
Anamorelin (ADLUMIZ): GHS-R1a Agonist for Cancer Cachexia—Mechanism, Use, and Safety Boundaries
9
Vemurafenib Mechanism and Clinical Indications: BRAF V600E Mutant Melanoma and ECD Treatment
10
Anagrelide Cautions and Contraindications: Allergy, Hepatic, Cardiac and Bleeding Risks
11
FDA Accelerated Approval of Voceryq: First Plasmid DNA Immunotherapy for Adult Recurrent Respiratory Papillomatosis
12
Ribociclib: Mechanism of Action and Approved Uses in Breast Cancer